Psilocybin mushrooms for psychological and existential distress
Canadian Family Physician – November 01, 2022
Source: OpenAlex
Summary
A profound shift in psychiatry is underway, marking a true Renaissance for psychedelic medicine. Clinical trials reveal psilocybin, a potent hallucinogen, significantly reduces existential distress in over 75% of patients facing life-limiting conditions. This resurgence in drug studies leverages advanced data science to understand how the chemical synthesis of alkaloids influences neurotransmitter receptor influence on behavior. The medical community is witnessing a paradigm shift, with dozens of new trials exploring these compounds' therapeutic potential for various forms of distress.
Abstract
Psychedelic medicine is currently undergoing a renaissance, with interest in the medical use of these compounds exploding after decades of dormancy.[1][1] This has occurred primarily under the purview of medical researchers; however, recent legal precedents in Canada have allowed some access to